- Investor's Business Daily•12 hours ago
Vertex was the big winner Friday following a slew of biotechs and drugmakers issuing first-quarter reports Thursday.
- TheStreet.com•18 hours ago
Sarepta Therapeutics and Vertex Pharmaceuticals and Endo Pharmaceuticals were among the biotech stock movers Friday morning.
- Zacks•18 hours ago
Vertex Pharmaceuticals Incorporated (VRTX) reported first-quarter 2017 earnings per share of 13 cents (including the impact of stock-based compensation expense), which beat the Zacks Consensus Estimate of 4 cents.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||114.00 x 200|
|Ask||121.00 x 200|
|Day's Range||115.45 - 120.50|
|52 Week Range||71.46 - 120.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-257.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|